H2AX and prostate cancer: Previously, it was shown that the natural compound, resveratrol, which inhibits complex I of the ETC [60], sensitized radioresistant prostate cancer cells by increasing ATM phosphorylation and its target protein γ-H2AX, resulting in cell cycle arrest and subsequently cell death [61].